The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of dietary quality in patients on surveillance for colorectal cancer (CRC) using a computerized food frequency questionnaire (FFQ).
 
Rishi Jain
Research Funding - BeiGene (Inst); NGM Biopharmaceuticals (Inst); Zymeworks (Inst)
 
Jessie Rachel Panick
No Relationships to Disclose
 
Elizabeth A. Handorf
Honoraria - NCCN/Pfizer
Research Funding - NCCN/Lilly (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Flatiron Health
 
Karen Vincek
No Relationships to Disclose
 
Kara Stromberg
No Relationships to Disclose
 
Leah Fein
No Relationships to Disclose
 
Nicole Ross
No Relationships to Disclose
 
Jordan Senchak
No Relationships to Disclose
 
Jessica R Bauman
Consulting or Advisory Role - AstraZeneca; BeiGene; Blueprint Medicines; Janssen; Kura Oncology; Lilly; Merck; Pfizer; Turning Point Therapeutics
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Trident Pharmaceuticals
 
Michael J. Hall
Research Funding - Ambry Genetics; AstraZeneca; Caris Life Sciences; Foundation Medicine; InVitae; Myriad Genetics
Patents, Royalties, Other Intellectual Property - I share a patent with several Fox Chase investigators for a novel method to investigate hereditary CRC genes (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Caris Life Sciences; Myriad Genetics
Other Relationship - Caris Life Sciences; Foundation Medicine; Invitae; Myriad Genetics
 
Crystal S. Denlinger
Consulting or Advisory Role - Astellas Pharma; Bayer; BeiGene; Bristol Myer Squibb; Exelixis; Lilly; Merck; Taiho Pharmaceutical
Research Funding - Agios (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genmab (Inst); Lilly (Inst); Macrogenics (Inst); MedImmune (Inst); Sanofi (Inst); Zymeworks (Inst)
 
Carolyn Y Fang
Stock and Other Ownership Interests - Amgen; Amgen (I); Johnson & Johnson; Johnson & Johnson (I)